FK506与环孢素A治疗的心脏移植受者的急性排斥反应和心脏感染率：一项心内膜心肌活检病理研究 - Suppr | 超能文献

Acute rejection and heart infection rates in FK 506- versus cyclosporine A-treated heart transplant recipients: an endomyocardial biopsy pathologic study.

作者信息

Arbustini E, Dal Bello B, Rinaldi M, Diegoli M, Grasso M, Pellegrini C, Morbini P, Martinelli L, Bonora M R, Viganò M

出版信息

J Heart Lung Transplant. 1997 Sep;16(9):982-4.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Acute rejection and heart infection rates in FK 506- versus cyclosporine A-treated heart transplant recipients: an endomyocardial biopsy pathologic study.FK506与环孢素A治疗的心脏移植受者的急性排斥反应和心脏感染率：一项心内膜心肌活检病理研究

J Heart Lung Transplant. 1997 Sep;16(9):982-4.

2

Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.利用聚合酶链反应对小儿心脏移植受者的病毒感染进行诊断、监测和流行病学评估。

J Heart Lung Transplant. 1996 Feb;15(2):111-23.

3

Utility of surveillance biopsies in infant heart transplant recipients.监测活检在婴儿心脏移植受者中的应用价值。

J Heart Lung Transplant. 1995 Nov-Dec;14(6 Pt 1):1095-101.

4

Rescue photochemotherapy for the treatment of acute cardiac rejection in the absence of cyclosporine maintenance therapy.在无环孢素维持治疗的情况下，采用挽救性光化学疗法治疗急性心脏排斥反应。

J Heart Lung Transplant. 1998 Oct;17(10):1036-7.

5

FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.FK506在降低心脏移植后急性排斥反应中的有效性：一项前瞻性随机研究。

J Heart Lung Transplant. 1997 Oct;16(10):1001-10.

6

Heart allograft rejection under varying immunosuppressive protocols as evaluated by endomyocardial biopsy.通过心内膜心肌活检评估不同免疫抑制方案下的心脏同种异体移植排斥反应。

J Heart Transplant. 1986 Jul-Aug;5(4):279-85.

7

Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients.中国尸体肾移植受者中他克莫司与环孢素微乳剂治疗的配对肾分析

Transpl Int. 2006 Aug;19(8):657-66. doi: 10.1111/j.1432-2277.2006.00335.x.

8

Induction immunotherapy in heart transplantation with T10B9.1A-31: a phase I study.采用T10B9.1A-31进行心脏移植诱导免疫治疗：一项I期研究。

J Heart Lung Transplant. 1997 Sep;16(9):913-6.

9

The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.HLA错配和免疫抑制治疗对小儿心脏移植受者早期排斥反应结局的影响。

J Heart Lung Transplant. 1998 Dec;17(12):1195-200.

10

A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.一项针对初发肝移植受者的随机、前瞻性药物经济学试验，比较新山地明给药后2小时血药浓度监测与他克莫司谷浓度监测。

Liver Transpl. 2008 Feb;14(2):173-80. doi: 10.1002/lt.21355.

引用本文的文献

1

Differentiation Between Infection and Rejection in the Management of Cardiac Transplant Patients.心脏移植患者管理中感染与排斥反应的鉴别

Curr Infect Dis Rep. 2001 Aug;3(4):328-332. doi: 10.1007/s11908-001-0069-5.